Literature DB >> 6775697

Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent.

S B Prusiner, D F Groth, S P Cochran, F R Masiarz, M P McKinley, H M Martinez.   

Abstract

The scrapie agent causes a progressive degeneration of the central nervous system of animals after a prolonged incubation period. Measurements of incubation period length, defined as the time from inoculation to the onset of clinical signs of neurological dysfunction, were related to the titer of the agent and the dilution of the inoculated sample. Equations defining the relationship provide a new assay for the agent requiring fewer animals than end point titrations. By use of this incubation period assay, the scrapie agent from hamster brain was found to have an s20,w of < 300 S but > 30 S assuming rho p = 1.2 g/cm3. A partially purified fraction P3 was obtained by differential centrifugation and sodium deoxycholate extraction. When P3 was extracted with phenol, virtually no infectivity was found in the aqueous phase even after examining such variables as pH, salt concentration, and predigestion of samples with proteinase K. Nonionic and nondenaturing, anionic detergents did not inactivate the scrapie agent; in contrast, denaturing detergents inactivated the agent. Sodium dodecyl sulfate (NaDodSO4) inactivated greater than 90% of the agent at a NaDodSO4 to protein ratio of 1.8 g/g. Inactivation by NaDodSO4 appears to be a cooperative process. Addition of a nonionic detergent to form mixed micelles with NaDodSO4 prevented inactivation of the agent by NaDodSO4. Weak chaotropic ions do not inactivate the scrapie agent while strong chaotropic ions like SCN- and Cl3CCOO- destroy infectivity at concentrations of 0.2 M. These data provide evidence in support of a protein component within the scrapie agent which is essential for maintenance of infectivity. Thus, it is unlikely that the scrapie agent is composed only of a "naked" nucleic acid as is the case for the plant viroids.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6775697     DOI: 10.1021/bi00562a028

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  47 in total

1.  Theoretical modeling of prion disease incubation.

Authors:  R V Kulkarni; A Slepoy; R R P Singh; D L Cox; F Pázmándi
Journal:  Biophys J       Date:  2003-08       Impact factor: 4.033

2.  Use of proteinase K nonspecific digestion for selective and comprehensive identification of interpeptide cross-links: application to prion proteins.

Authors:  Evgeniy V Petrotchenko; Jason J Serpa; Darryl B Hardie; Mark Berjanskii; Bow P Suriyamongkol; David S Wishart; Christoph H Borchers
Journal:  Mol Cell Proteomics       Date:  2012-03-21       Impact factor: 5.911

3.  Lower specific infectivity of protease-resistant prion protein generated in cell-free reactions.

Authors:  Mikael Klingeborn; Brent Race; Kimberly D Meade-White; Bruce Chesebro
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

Review 4.  Transmissible spongiform encephalopathies (TSE) virus-induced amyloidoses of the central nervous system (CNS).

Authors:  H Diringer
Journal:  Eur J Epidemiol       Date:  1991-09       Impact factor: 8.082

Review 5.  Prion propagation: the role of protein dynamics.

Authors:  John A Pezza; Tricia R Serio
Journal:  Prion       Date:  2007-01-10       Impact factor: 3.931

Review 6.  Prion liposomes.

Authors:  R Gabizon; S B Prusiner
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

7.  Immunological analysis of host and agent effects on Creutzfeldt-Jakob disease and scrapie prion proteins.

Authors:  J M Bockman; D T Kingsbury
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

8.  Ultrastructural studies on scrapie prion protein crystals obtained from reverse micellar solutions.

Authors:  H Wille; S B Prusiner
Journal:  Biophys J       Date:  1999-02       Impact factor: 4.033

9.  Recombinant scrapie-like prion protein of 106 amino acids is soluble.

Authors:  T Muramoto; M Scott; F E Cohen; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

10.  Scrapie and Creutzfeldt-Jakob disease prion proteins share physical properties and antigenic determinants.

Authors:  P E Bendheim; J M Bockman; M P McKinley; D T Kingsbury; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.